FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Advanced Accelerator Applications Netspot Recall

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Int…

Advanced Accelerator Applications USA, Inc. · Millburn, NJ

Risk level
Class II
Reported by FDA
Jan 29, 2020
Recall ID
D-0799-2020
Check your lot numberHow we source this data

Summary

Advanced Accelerator Applications recalled Netspot starting Jan 10, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0799-2020 on Jan 29, 2020. Reason: Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2). Status: Terminated.

Why it was recalled

Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).

Product description

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

Lot numbers, UPCs & expiration codes

Lot #: PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.

Where it was sold

Nationwide in the US and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0799-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 10, 2020
FDA report date
Jan 29, 2020
Quantity
4295 Kits
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Accelerator Applications USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0799-2020, exactly as published.

Show all FDA fields
City
Millburn
State
NJ
Status
Terminated
Country
United States
Event ID
84685
Address
57 E Willow St
Code information
Lot #: PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.
Postal code
07041-1416
Report date
Jan 29, 2020
Product type
Drugs
Recall number
D-0799-2020
Classification
Class II
Recalling firm
Advanced Accelerator Applications USA, Inc.
Product quantity
4295 Kits
Termination date
Jul 21, 2023
Reason for recall
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Voluntary / mandated
Voluntary: Firm initiated
Product description
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.
Distribution pattern
Nationwide in the US and Canada
Recall initiation date
Jan 10, 2020
Initial firm notification
Letter
Center classification date
Jan 22, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0799-2020, published Jan 29, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls